We conclude that this study advances our understanding of the immunoregulatory mechanisms involved in intravenous injected IL-1β-hUCMSCs in a RA mice model and hints at the potential of hUCMSCs for RA therapy. This evidence concerns the gene IL1B and rheumatoid arthritis.